Slide 1: Optomed Q3 2023
Optomed Q3 2023 3rd November 2023 Juho Himberg, CEO Sakari Knuutti, CFO
Slide 2: Q3-2023 Highlights
Q3-2023 Highlights 1. 2. 3. Excellent operational Record-breaking Directed share issue results in both operational cash flow raised gross proceeds segments of EUR 4.3 million
Slide 3: Q3-2023 Key Figures
Q3-2023 Key Figures WE ACHIEVED DOUBLE DIGIT GROWTH AND IMPROVED OUR PROFITABILITY DURING THE QUARTER Q3/2023 Q3/2022 Change Revenue 4,218 3,700 14.0% Gross profit 1) 2,841 2,967 -4.2% Gross margin 2) 67.4% 80.2% -12.8pps Adjusted EBITDA 3) 263 145 80.9% Adjusted EBITDA margin 4) 6.2% 3.9% 2.3pps Ne
Slide 4: Q1-Q3 2023 Key Figures
Q1-Q3 2023 Key Figures THE OPERATIONAL IMPROVEMENT IS ALSO VISIBLE ON OUR YEAR-TO-DATE FIGURES Q1-3/2023 Q1-3/2022 Change Revenue 11,440 10,648 7.4% Gross profit 1) 7,803 7,305 6.8% Gross margin 2) 68.2% 68.6% -0.4pps Adjusted EBITDA 3) -713 -1,604 55.6% Adjusted EBITDA margin 4) -6.2% -15.1% 8.9pps
Slide 5: Segment highlights
Segment highlights OPT@MED
Slide 6: Devices Segment Q3-2023
Devices Segment Q3-2023 DEVICES SEGMENT GREW ALMOST 8 % Q3/2023 Q3/2022 Change Revenue increased 7.5 % driven 1. by global distributor and China sales channels Revenue 1,825 1,697 7.5 % Gross margin adjusted for grants and 1,124 1,592 -29.4 % Gross profit 2. other operating income was 61.9 (44.2) pe
Slide 7: Software Segment Q3-2023
Software Segment Q3-2023 SOFTWARE SEGMENT GREW ALMOST 20 % Q3/2023 Q3/2022 Change Revenue increased by 19.4 % 1. and EBITDA margin improved significantly Revenue 2,393 2,003 19.4 % The increase was driven by very Gross profit 1,718 1,374 25.0 % 2. strong performance of the healthcare solution busine
Slide 8: Cash Flow Q3-2023
Cash Flow Q3-2023 RECORD BREAKING CASHFLOW FROM OPERATING ACTIVITIES Q3 2023 Q3 2022 Loss for the financial year -439 -1,377 Cash flows before change in net working capital 402 -565 • Net cash from operating activities was EUR 0.77 million Change in net working capital 464 117 positive Cash flows be
Slide 9: New Business Model
New Business Model SIGNIFICANT RECURRING REVENUE OPPORTUNITY IN THE US Complete Solution Recurring Revenue Model Customer Benefits Newly established From product sales to Solution leased, reimbursement complete screening No initial investments not sold – enables code CPT 92229 solutions with diagnos
Slide 10: Summary
Summary • Excellent operational results in both segment • Record-breaking operational cash flow • We are well positioned for the next phase of growth
Slide 11: Appendix
Appendix
Slide 12: Devices Segment: Key Financials Q1-Q3 2023
Devices Segment: Key Financials Q1-Q3 2023 1-9/2023 1-9/2022 Change % Revenue 3,986 4,122 -3.3 % Gross profit 2,356 2,875 -18.0 % Gross margin 59.1 % 69.7 % EBITDA -693 -417 -66.2 % EBITDA margin -17.4 % -10.1 %
Slide 13: Software Segment: Key Financials Q1-Q3 2023
Software Segment: Key Financials Q1-Q3 2023 1-9/2023 1-9/2022 Change % Revenue 7,454 6,525 14.2 % Gross profit 5,447 4,430 22.9 % Gross margin 73.1 % 67.9 % EBITDA 2,004 1,373 46.0 % EBITDA margin 26.9 % 21.0 %
Slide 14: Cash Flow: Q1-Q3 2023
Cash Flow: Q1-Q3 2023 1-9/2023 1-9/2022 Loss for the financial year -2,911 -4,075 Cash flows before change in net working capital -546 -2,204 Change in net working capital 595 243 Cash flows before finance items 50 -1,962 Cash flows from finance items -169 -132 Net cash from operating activities -12
Slide 15: Balance Sheet
Balance Sheet 30 September 2023 30 September 2022 ASSETS Goodwill 4,256 4,256 • Equity ratio of 68.9 (63.3) Development costs 7,493 6,287 Other intangible assets 1,842 2,139 percent Total intangible assets 13,592 12,683 Total tangible assets 747 932 • Total borrowings of EUR 4.7 Total non-current as